Why do low-income minority parents choose human papillomavirus vaccination for their daughters?
OBJECTIVE
To explore low-income minority parents' attitudes, intentions, and actions with regard to human papillomavirus (HPV) vaccination for their daughters.


METHODS
Semistructured interviews were conducted in English and Spanish with parents of girls aged 11-18 who were attending clinic visits in an urban medical center and a community health center. We assessed intention with formal scales, probed parents' attitudes regarding vaccination with open-ended questions, and reviewed medical records to determine vaccination rates. Data were analyzed using descriptive statistics and qualitative methods.


RESULTS
Seventy-six parents participated (43% African American, 28% Latino, and 26% Caucasian). Most were mothers, had completed high school, and described themselves as religious; nearly one-half were immigrants. Intention correlated highly with receipt of the vaccine; 91% of parents intended to vaccinate their daughters against HPV, and 89% of the girls received vaccination within 12 months of the interview. Qualitative analysis revealed that most parents focused on the vaccine's potential to prevent cervical cancer. Some parents expressed concerns about unknown side effects and promotion of unsafe sexual practices, but these concerns did not hinder acceptance in most cases.


CONCLUSIONS
The majority of the low-income minority parents surveyed viewed HPV vaccination as a way to protect their daughters from cancer, and thus chose to vaccinate their daughters.
Perkins
Rebecca B
RB
Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, MA 02118, USA. Rebecca.perkins@bmc.org
Pierre-Joseph
Natalie
N
Marquez
Cecilia
C
Iloka
Sandra
S
Clark
Jack A
JA
D000293:Adolescent; D001741:Black or African American / Q000706:statistics & numerical data; D001294:Attitude to Health; D002648:Child; D002755:Choice Behavior; D005260:Female; D006801:Humans; D008913:Minority Groups / Q000706:statistics & numerical data*; D009679:Nuclear Family / Q000208:ethnology*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D010290:Parents; D012959:Socioeconomic Factors; D011795:Surveys and Questionnaires; D014611:Vaccination / Q000706:statistics & numerical data*; D044465:White People / Q000706:statistics & numerical data
D053918:Papillomavirus Vaccines
MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24
17380109
Vaccine. 2006 Aug 31;24 Suppl 3:S3/26-34
16950015
JAMA. 2007 Feb 28;297(8):813-9
17327523
J Adolesc Health. 2009 May;44(5):446-51
19380091
Obstet Gynecol. 2007 Jul;110(1):87-95
17601901
Womens Health Issues. 2002 May-Jun;12(3):122-8
12015184
J Adolesc Health. 2009 May;44(5):437-45
19380090
J Adolesc Health. 2005 Sep;37(3):248-51
16109349
Arch Pediatr Adolesc Med. 2005 Oct;159(10):971-6
16203943
Med Care. 2008 Oct;46(10):1086-92
18815531
J Womens Health (Larchmt). 2009 Feb;18(2):225-33
19183094
J Adolesc Health. 2008 Sep;43(3):239-45
18710678
Pediatrics. 2006 May;117(5):1486-93
16651301
JAMA. 2004 May 12;291(18):2197-203
15138241
JAMA. 1992 Dec 9;268(22):3219-23
1433762
J Adolesc Health. 2007 Feb;40(2):108-15
17259050
Gynecol Oncol. 2009 Mar;112(3):577-82
19150120
Public Health Rep. 2003 Jul-Aug;118(4):358-65
12815085
JAMA. 1991 Jan 9;265(2):233-7
1984153
Am J Prev Med. 1997 Nov-Dec;13(6):418-24
9415785
J Low Genit Tract Dis. 2004 Jul;8(3):188-94
15874862
Infect Dis Obstet Gynecol. 2006;2006 Suppl:40470
16967912
Soc Sci Med. 2004 Apr;58(7):1405-13
14759685
MMWR Morb Mortal Wkly Rep. 2009 Aug 28;58(33):921-6
19713881
JAMA. 1989 Jan 13;261(2):278-81
2909026
Lancet Oncol. 2005 May;6(5):271-8
15863374
J Gen Intern Med. 2003 Dec;18(12):1028-35
14687262